ATE256184T1 - Promotor des utrophingens - Google Patents

Promotor des utrophingens

Info

Publication number
ATE256184T1
ATE256184T1 AT96911038T AT96911038T ATE256184T1 AT E256184 T1 ATE256184 T1 AT E256184T1 AT 96911038 T AT96911038 T AT 96911038T AT 96911038 T AT96911038 T AT 96911038T AT E256184 T1 ATE256184 T1 AT E256184T1
Authority
AT
Austria
Prior art keywords
pct
promoter
utrophin
date oct
sec
Prior art date
Application number
AT96911038T
Other languages
English (en)
Inventor
Jonathon Mark Tinsley
Kay Elizabeth Davies
Carina Dennis
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508236.8A external-priority patent/GB9508236D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE256184T1 publication Critical patent/ATE256184T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4707—Muscular dystrophy
    • C07K14/4708—Duchenne dystrophy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96911038T 1995-04-24 1996-04-24 Promotor des utrophingens ATE256184T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9508236.8A GB9508236D0 (en) 1995-04-24 1995-04-24 Promoting gene expression
GBGB9526028.7A GB9526028D0 (en) 1995-04-24 1995-12-20 Promoting gene expression
PCT/GB1996/000979 WO1996034101A1 (en) 1995-04-24 1996-04-24 Utrophin gene promoter

Publications (1)

Publication Number Publication Date
ATE256184T1 true ATE256184T1 (de) 2003-12-15

Family

ID=26306918

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96911038T ATE256184T1 (de) 1995-04-24 1996-04-24 Promotor des utrophingens

Country Status (7)

Country Link
US (1) US5972609A (de)
EP (1) EP0824589B1 (de)
JP (1) JP4364941B2 (de)
AT (1) ATE256184T1 (de)
AU (1) AU712450B2 (de)
DE (1) DE69631041T2 (de)
WO (1) WO1996034101A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7306903B1 (en) 1995-07-26 2007-12-11 Curis, Inc. Methods and compositions for identifying morphogen analogs
US6103491A (en) * 1995-07-26 2000-08-15 Creative Biomolecules, Inc. Methods and compositions for identifying morphogen analogs
US6090544A (en) * 1995-07-26 2000-07-18 Creative Biomolecules, Inc. Methods and compositions for identifying morphogen analogs
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6911307B1 (en) * 1998-12-08 2005-06-28 Proteus S.A. Method of detection in vitro of a target substance in a sample comprising the labelling of said substance with a reporter gene and with the sequences necessary for the expression of said reporter gene in vitro
GB9923423D0 (en) * 1999-10-04 1999-12-08 Isis Innovation Promoting gene expression
AU2002219070A1 (en) * 2000-11-02 2002-05-15 Myocontractag Ets-transcription factor related compound specific promoter and transactivators thereof
KR101666228B1 (ko) 2007-09-28 2016-10-13 인트렉손 코포레이션 생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도

Also Published As

Publication number Publication date
EP0824589B1 (de) 2003-12-10
JP4364941B2 (ja) 2009-11-18
US5972609A (en) 1999-10-26
DE69631041T2 (de) 2004-09-02
AU5404396A (en) 1996-11-18
DE69631041D1 (de) 2004-01-22
EP0824589A1 (de) 1998-02-25
AU712450B2 (en) 1999-11-04
WO1996034101A1 (en) 1996-10-31
JPH11504515A (ja) 1999-04-27

Similar Documents

Publication Publication Date Title
Nissen et al. Molecular analysis of the transcriptional regulatory region of an early baculovirus gene
Nordqvist et al. Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs
Frankel et al. Cellular uptake of the tat protein from human immunodeficiency virus
Jones et al. Control of gene expression by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Multiple dioxin-responsive domains 5'-ward of the cytochrome P1-450 gene.
Abeles et al. P1 plasmid replication: replicon structure
Magnuson et al. Multihormonal regulation of phosphoenolpyruvate carboxykinase-chloramphenicol acetyltransferase fusion genes. Insulin's effects oppose those of cAMP and dexamethasone.
Skalnik et al. The membrane domain of 3-hydroxy-3-methylglutaryl-coenzyme A reductase confers endoplasmic reticulum localization and sterol-regulated degradation onto beta-galactosidase.
Jones et al. Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3′ untranslated sequences
US5358857A (en) Method of preparing fusion proteins
Meyuhas et al. The mouse ribosomal protein L7 gene. Its primary structure and functional analysis of the promoter region.
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
GEP20022701B (en) Modulators of Body Weight, Corresponding Nucleic Acids and Proteins, and Diagnostic and Therapeutic Uses Thereof
Widen et al. Liver-specific expression of the mouse alpha-fetoprotein gene is mediated by cis-acting DNA elements.
CA2205874A1 (en) Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
IL114820A0 (en) Method for selecting high-expressing host cells
Thompson et al. In vitro methylation of the promoter and enhancer of Pro alpha 1 (I) collagen gene leads to its transcriptional inactivation
Hwung et al. Cooperativity of sequence elements mediates tissue specificity of the rat insulin II gene
ATE256184T1 (de) Promotor des utrophingens
DE69322166D1 (de) Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon
WO1996003506A3 (en) Analog of haemophilus hin47 with reduced protease activity
ATE417114T1 (de) Promotor des utrophingens
Hoffman et al. The ovarian, ecdysterone, and heat-shock-responsive promoters of the Drosophila melanogaster hsp27 gene react very differently to perturbations of DNA sequence
Milton et al. In vitro mutagenesis and overexpression of the Escherichia coli trpA gene and the partial characterization of the resultant tryptophan synthase mutant alpha-subunits.
CA2083396A1 (en) Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
Bourdineaud et al. Characterization of the arcD arginine: ornithine exchanger of Pseudomonas aeruginosa. Localization in the cytoplasmic membrane and a topological model.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0824589

Country of ref document: EP

REN Ceased due to non-payment of the annual fee